Research	Preclinical	Phase 1	Phase 2	Phase 3	Postmarketing Studies
GENETIC DISEASES
Fabrazyme Fabry disease
Myozyme Pompe disease
Genz-112638 oral therapy Gaucher disease
Ataluren Duchenne and Becker muscular dystrophy
Acid Sphingomyelinase Niemann-Pick Type B
Gene Therapy Parkinson's disease
Neo-GAA next generation Pompe disease treatment
CARDIOMETABOLIC / RENAL
Cholestagel familial hypercholesterolemia
Renvela chronic kidney disease not on dialysis
Mipomersen familial hypercholesterolemia
Mipomersen severe hypercholesterolemia
TSH nontoxic multinodular goiter
Genz-644470 advanced phosphate binder chronic kidney disease
GC1008 kidney sclerosis
HEMATOLOGIC ONCOLOGY
Campath combination CLL
Prochymal graft vs. host disease
Clolar combination adult rel/ref AML
Clolar adult AML
Thymoglobulin myelodysplastic syndromes
Mozobil tumor sensitization
Clolar combination pediatric rel/ref ALL and AML
Clolar oral myelodysplastic syndromes
GC1008 solid tumors
TRANSPLANT / IMMUNE DISEASES
Alemtuzumab multiple sclerosis
Prochymal Crohn's disease
Thymoglobulin liver transplant
Hectorol psoriasis
GC1008 pulmonary fibrosis
Mozobil solid organ transplant/autoimmune disease
BIOSURGERY
Synvisc-One osteoarthritis pain relief
Hylastan (EU) new formulation
SepraSpray (EU) post-surgical adhesions
MACI articular cartilage defects
Chondrogen osteoarthritis
SepraSpray (US) post-surgical adhesions
Gen-S osteoarthritis pain relief

Genetics/Diagnostics Pipeline

	Research	Development
REPRODUCTIVE/GENETICS
Array comparative genomic hybridization
Reproductive molecular assays
Pregnancy management biomarkers
ONCOLOGY
ERCC1 non-small cell lung cancer
Image analysis solid tumors
RAPID TESTS
Respiratory Syncytial Virus (RSV)
C. difficile Toxins A & B
CLINICAL CHEMISTRY REAGENTS
FGF23 renal
GL-3 renal
KIM-1 renal

Terms and Conditions of Use | Privacy Policy | © 2002-2009 Genzyme Corporation. All rights reserved.